MedBen Blog

Keeping You Informed.
get started

RxDC Reporting Made Easy for MedBen Clients

As you may recall, the Consolidated Appropriations Act of 2021 (CAA) requires group health plans to submit to the Centers for Medicare & Medicaid Services information about prescription drugs and health care spending. This data submission is called RxDC (for...

read more

A New Warning on Women’s Heart Health

Heart disease risk among women is rising — and younger women are no longer considered low risk. A new scientific statement from the American Heart Association warns that women ages 20–44 and women of color face disproportionate risk, and by 2050, 6 in 10 U.S. women...

read more

The High Cost of Avoidable ER Visits

For MedBen clients in 2025, 14% of emergency room visits were identified as potentially avoidable — often for conditions that could have been treated safely and effectively in a more appropriate setting. When care is delivered at an urgent care facility or physician’s...

read more

Biosimilars Takes Aim at Rising Specialty Drug Costs

Specialty medications continue to dominate pharmacy spend, now accounting for 52% of all U.S. pharmaceutical sales, according to a recent report from the Healthcare Distribution Alliance. With costs often reaching tens — or even hundreds — of thousands of dollars per...

read more

Stay on Track with the Compliance Deadlines List

MedBen’s Compliance team reminds you that our “Self-Funded Plan Sponsors Annual Compliance Deadlines” list is available to help clients stay current with mandatory health plan regulatory requirements.  MedBen clients can acquire this valuable reference document MedBen...

read more

Where TrumpRx Can Add Value for Self-Funded Pharmacy Plans

The February 5th launch of the TrumpRx.gov online portal has generated attention for its lower prescription drug pricing… and may offer value for self-funded pharmacy plans in cases where medications are excluded from coverage or members face high upfront costs. While...

read more

Cancer Survival Reaches Historic Milestone

The fight against cancer has reached a major turning point. According to the American Cancer Society (ACS), seven in 10 people diagnosed with cancer in the U.S. now survive at least five years — a milestone that reflects decades of progress in prevention, detection,...

read more

Federal Actions Put PBMs Under the Microscope

Pharmacy benefit managers continue to draw scrutiny in Washington, and two recent federal actions signal that greater transparency and oversight may be on the horizon. One is a newly enacted funding law that includes PBM reforms, and the other is a proposed Department...

read more